1 / 69

AFP Journal Review December 1, 2012

Lianne Beck, MD Assistant Professor Emory Family Medicine. AFP Journal Review December 1, 2012. Articles . Treatment and Prevention of Kidney Stones: An Update Diagnosis and Management of Rheumatoid Arthritis Personality Disorders: Review and Clinical Application in Daily Practice

nusa
Download Presentation

AFP Journal Review December 1, 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Lianne Beck, MD Assistant Professor Emory Family Medicine AFP Journal Review December 1, 2012

  2. Articles • Treatment and Prevention of Kidney Stones: An Update • Diagnosis and Management of Rheumatoid Arthritis • Personality Disorders: Review and Clinical Application in Daily Practice • Management of Falls in Older Persons: A Prescription for Prevention

  3. Treatment and Prevention of Kidney Stones: An Update • 10-15% risk in the US • Risk factors include obesity, insulin resistance, gastrointestinal pathology, living in warmer climates, certain dietary patterns and medications • Clinical presentation: Cramping, intermittent abdominal and flank pain, hematuria, nausea or vomiting, and malaise; fever and chills. May be asymptomatic

  4. DDX • UTI/pyelonephritis • Interstitial cystitis, vaginitis, prostatitis • Cholelithiasis, cholecystitis • Musculoskeletal • PID • Renal or bladder neoplasm

  5. DIAGNOSTIC WORK UP • UA • Urine cultures if febrile or leukocytes on UA • Plain radiograph. Uric acid stones and stones associated with protease inhibitor use may not be visible on a radiograph • US or spiral computed tomography can detect all types of kidney stones and may be necessary if the diagnosis is in question.

  6. When to Refer • > 1 stone • Sx’s worsen with fever • Renal function is impaired • Stone passage is prolonged • Hydronephrosis • Pregnant • Stone is larger than 5 mm

  7. Further Evaluation • History: IBD, bowel surgery, gout, DM, obesity or recent changes in weight, metabolic syndromes, hyperparathyroidism-associated conditions, frequent UTIs, CKD • Family History • Medications • 24-hour urine for calcium, phosphorus, magnesium, uric acid, and oxalate to determine stone composition • Serum Ca, Mg, Phos • Urine pH and specific gravity • Stone analysis

  8. Prevention • Depends on the specific type of kidney stone and urine characteristics • All types: • Fluids (sp grav > 1.1015) • Wt loss • Glucose control • Check PTH if serum Ca elevated • Alkalinize or acidify urine based on pH and type of stone

  9. Prevention • Calcium oxalate, cystine, and uric acid stones - urine should be alkalinized by eating a diet high in fruits and vegetables, taking supplemental or prescription citrate, or drinking alkaline mineral waters. • Calcium phosphate and struvite stones -urine should be acidified with cranberry juice or betaine.

  10. Alkalinize • Potassium citrate: 10 to 20 mEq orally with meals (prescription required) • Calcium citrate: two 500-mg tablets per day with meals (each tablet contains 120 mg of calcium and 6 mEq of bicarbonate) • Acidify • Cranberry juice: at least 16 oz per day • Betaine: 650 mg orally three times per day with meals

  11. Can Bacterial Infection Trigger Recurrence? • Bacteria exert both pathogenic and protective roles. • Struvite stones are associated with recurrent infections because of high urinary pH levels from urease splitting bacteria • Oxalobacter formigenes is an anaerobic bacterium that colonizes the intestinal tract, where it metabolizes oxalate to formate and carbon dioxide. • Absence of O. formigenes colonization predisposes persons to oxalate stones

  12. Obesity • Weight loss could be detrimental to prevention of kidney stones if associated with a high animal protein diet, laxative abuse, rapid loss of lean tissue, or poor hydration. • High acid diets, such as the Atkins diet, increase the risk of uric acid stones.

  13. Fructose • Associated with up to a 38 % higher risk of kidney stones. • Increased fructose intake increases urinary calcium excretion in persons with magnesium deficiency • Fructose is the only dietary carbohydrate known to raise uric acid levels. • Sugar-sweetened beverages and orange juice have been linked to gout.

  14. ALTERNATIVE THERAPIES • Acupuncture and chiropractic manipulation may ease stone passage in patients with nerve impingement. • Phytonutrients in green tea, turmeric, and berries may reduce the risk of infection • Parsley may promote diuresis • The herb Agropyron repens may help achieve flushing of the urinary tract

  15. Diagnosis and Management of RA • The most common inflammatory arthritis, with a lifetime prevalence of up to 1 % worldwide. • Onset peaks between 30 and 50 years. • In a large U.S. cohort, 35% of patients with RA had work disability after 10 years. • 50% of RA risk attributable to genetic factors • Smoking is the major environmental trigger for RA

  16. Pathophysiology • Characterized by inflammatory pathways that lead to proliferation of synovial cells in joints. • Pannus formation leads to underlying cartilage destruction and bony erosions. • Overproduction of proinflammatory cytokines, including TNF and IL-6

  17. Risk Factors • Older age • Family history • Female sex • Smoking • Early menarche (RR = 1.3 for those with menarche at 10 years of age or younger) and very irregular menstrual periods (RR = 1.5) increase risk. • Pregnancy often causes RA remission • Multiparity decreases risk • Breastfeeding decreases risk

  18. Presentation • Pain and morning stiffness, lasting more than one hour, that involves wrists, proximal interphalangeal joints, and metacarpophalangeal joints • Boggy swelling due to synovitis or subtle synovial thickening may be palpable on joint examination. • Patients may also present with more indolent arthralgias before the onset of clinically apparent joint swelling. • Fatigue, weight loss, low-grade fever may occur with active disease.

  19. Figure 1. Boggy swelling in proximal interphalangeal and metacarpophalangeal joints (more prominent on patient's right hand) in a patient with new-onset rheumatoid arthritis. Note that with joint swelling, the skin creases over the proximal interphalangeal joints become less apparent

  20. DIAGNOSTIC TESTS • 50 to 80% of persons with RA have RF, anti-CCP, or both. • ANA is of prognostic importance in juvenile forms of this disease. • CRP and ESR are often increased with active RA and used to follow disease activity and response to medication. • CBC, renal and hepatic function • Xray of hands and feet to evaluate for periarticular erosive changes, which may be indicative of a more aggressive RA subtype.

  21. DDX • Osteoarthritis • SLE • Systemic sclerosis • Psoriatic arthritis • PMR • Sarcoidosis • Spondyloarthropathy • Viral process • Gout or pseudogout • Fibromyalgia • Thyroid disorders • Vit D deficiency

  22. Treatment • DMARDS • Biologic agents: monoclonal antibodies and recombinant receptors block cytokines that promote the inflammation • Nonbiologic agents: • Methotrexate recommended as the first-line treatment in patients with active RA. • Leflunomide (Arava) used as an alternative to methotrexate, although GI adverse effects are more common. • Sulfasalazine (Azulfidine) or hydroxychloroquine (Plaquenil) is recommended as monotherapy in patients with low disease activity or without poor prognostic features (e.g., seronegative, nonerosive RA).

  23. DMARDS cont… • Combination therapy with two or more DMARDs is more effective than monotherapy. • If RA is not well controlled with a nonbiologic DMARD, a biologic DMARD should be initiated. • TNF inhibitors are the first-line biologic therapy and are the most studied of these agents. • If TNF inhibitors are ineffective, additional biologic therapies can be considered. • Simultaneous use of more than one biologic therapy (e.g., adalimumab [Humira] with abatacept [Orencia]) is not recommended because of an unacceptable rate of adverse effects.

  24. Treatment

  25. Others • NSAIDs and corticosteroids only for short-term • CAM: gamma-linolenic acid (from evening primrose or black currant seed oil) and Tripterygium wilfordii (thunder god vine) have potential benefits • Exercise and PT

  26. Prognosis • Remission in 10 to 50 % of patients • More likely in males, nonsmokers, <40 yo, late-onset disease (> 65 years), shorter duration of disease, milder disease activity, without elevated acute phase reactants, and without positive RF or anti-CCP. • After the disease is controlled, medication dosages may be cautiously decreased to the minimum amount necessary. • Patients require frequent monitoring to ensure stable symptoms, and prompt increase in medication is recommended with disease flare-ups.

  27. Prognosis • Patients with RA live three to 12 years less than the general population. • Increased mortality due to accelerated cardiovascular disease, especially in those with high disease activity and chronic inflammation.

  28. Cardiovascular Disease

  29. Personality Disorders • DSM IV: “an enduring pattern of inner experience and behavior that deviates markedly from the expectations of the individual's culture.” • The pattern is inflexible and pervasive across a broad range of personal and social situations • Leads to clinically significant distress or impairment in social, occupational, or other important areas of functioning • Stable and of long duration • Onset traceable to at least adolescence or early adulthood

  30. Personality Disorders • 9 to 14.8 % of patients have at least one personality disorder • Many patients have multiple personality disorders or traits that span several types of disorders • Significant comorbidity exists with alcohol and chemical abuse, and with anger traits • Personality disorders tend to be stable over time • Treatments: CBT, DBT, mentalization-based therapy, transference-focused psychotherapy, and pharmacotherapy (e.g., typical and atypical antipsychotics, antidepressants, mood stabilizers)

  31. Personality Disorder Types • Classified into clusters A, B, and C. • Cluster A: odd or eccentric personalities, includes paranoid, schizoid, and schizotypal personality disorders. • Cluster B: dramatic, emotional, or erratic personalities, includes antisocial, borderline, histrionic, and narcissistic personality disorders. • Cluster C: anxious or fearful, include avoidant, dependent, and obsessive-compulsive personality disorders

More Related